Poster Abstract Session:
224. Antiviral Therapies
Saturday, October 6, 2018: 12:30 PM-1:45 PM
Room: S Poster Hall

Tracks: Adult ID, Epidemiology and Infection Control, Investigative ID, Pediatric ID

The Anti-Parasitic Drug Atovaquone Inhibits Arbovirus Replication
Angelica Kottkamp, MD; Elfie DeJesus, B.S.; Kenneth Stapleford, PhD
  • Atovaquone ID week poster.pdf (494.7 kB)
  • Letermovir Salvage for Complicated Cases of Resistant CMV
    Nicholas Turner, MD; Andrew Strand, MD; Jennifer Saullo, MD, PharmD; Sana Arif, MBBS; Eileen K. Maziarz, MD; Dilraj Grewal, MD; Arthur W. Baker, MD, MPH; Cameron R. Wolfe, MBBS (Hons), MPH, FIDSA
    Clinical Characteristics of Patients (pts) with Solid Organ Transplantation (SOT) and Norovirus (NV) Infections
    Verena König, Medical Student; Jörg Hofmann, PhD; Markus Tölle, MD; Petra Reinke, MD; Susanne Brakemeier, MD; Stefan Schwartz, MD
  • IDWeek2018 Poster 1898.pdf (59.8 kB)
  • The cellular kinase inhibitor OSU-03012 inhibits enterovirus 71 in vitro
    Jasper Chan, MD; Jessica Tsang, BSc; Zijiao Zou, MPhil; Kenn Chik, MMedSc; Shuofeng Yuan, PhD; Hin Chu, PhD; Susanna Lau, MD; Kwok-Yung Yuen, MD
    Low Prevalence of Protective Antibodies to Measles among Young Adults in Argentina
    Emiliano Bissio, MD; Cristián Biscayart, MD; Veronica Cisneros, MD; Maria Eugenia Perez Carrega, MD; Isabel Cassetti, MD; Jose Luis Montes, MD
  • Safety, Tolerability and Efficacy of Fluoxetine as an Antiviral for Enterovirus D68 Associated Acute Flaccid Myelitis: A Retrospective Multicenter Cohort Study
    Kevin Messacar, MD; Stefan Sillau, PhD; Sarah Hopkins, MD; Catherine Otten, MD; Molly Wilson-Murphy, MD; Brian Wong, MD; Jonathan Santoro, MD; Andrew Treister, MD; Harlori Tokhie, MD; Alcy Torres, MD; Luke Zabrocki, MD; Julia Glanternik, MD; Amanda L. Hurst, PharmD; Jan Martin, MD; Teri Schreiner, MD; Naila Makhani, MD; Roberta DeBiasi, MD, MS, FIDSA, FPIDS; Michael Kruer, MD; Adriana H. Tremoulet, MD, MAS; Keith Van Haren, MD; Jay Desai, MD; Leslie Benson, MD; Mark Gorman, MD; Mark Abzug, MD; Kenneth Tyler, MD; Samuel Dominguez, MD, PhD

    CME Credits: Maximum of 0.00 hours of AMA PRA Category 1 Credit™

    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.